• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RotaLink? Advancer; catheter, coronary, atherectomy

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RotaLink? Advancer; catheter, coronary, atherectomy Back to Search Results
Model Number H80222782001A0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Bradycardia (1751); Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Tachycardia (2095); Ventricular Fibrillation (2130); Diminished Pulse Pressure (2606); Reduced Blood Flow (4598)
Date of Event 07/23/2026
Type of Reportable Event Death
Event or Problem Description
It was reported that the patient died.It was reported that the patient presented with severe chest pain.A rotalink advancer, 1.25 mm rotalink burr and rotawire drive were selected for treatment of the left circumflex (lcx) and left main (lm) arteries.Following rotablation, slow coronary flow was observed.Medications were administered to manage the patients condition.The patients blood pressure progressively declined and the patient experienced cardiac arrest.Direct current defibrillation and cardiopulmonary resuscitation were performed.Despite all efforts, there was no return of spontaneous circulation, no recordable pulse or blood pressure.The patient was declared dead.The official cause of death was slow flow and bradycardia.
 
Event or Problem Description
It was reported that the patient died.It was reported that the patient presented with severe chest pain.A rotalink advancer, 1.25 mm rotalink burr and rotawire drive were selected for treatment of the left circumflex (lcx) and left main (lm) arteries.Following rotablation, slow coronary flow was observed.Medications were administered to manage the patient's condition.The patients' blood pressure progressively declined, and the patient experienced cardiac arrest.Direct current defibrillation and cardiopulmonary resuscitation were performed.Despite all efforts, there was no return of spontaneous circulation, no recordable pulse or blood pressure.The patient was declared dead.The official cause of death was slow flow and bradycardia.It was further reported that the patient also presented with shortness of breath, dyspnea and chest heaviness.Injections of adrenaline, atropine, calcium gluconate 10 ml and amiodarone 150 mg were administered during the procedure.Intra-aortic balloon pump (iabp) and temporary pacemaker implantation (tpi) support was also provided.Patient was shifted to the critical care unit and place on mechanical ventilation.The patient experienced ventricular tachycardia and ventricular fibrillation.Hypotension and cardiac arrest were also noted as causes of death.
 
Additional Manufacturer Narrative
Good faith effort attempts were made to try and retrieve additional details regarding the reported event, but further information was unable to be obtained.
 
Event or Problem Description
It was reported that the patient died.It was reported that the patient presented with severe chest pain.A rotalink advancer, 1.25 mm rotalink burr and rotawire drive were selected for treatment of the left circumflex (lcx) and left main (lm) arteries.Following rotablation, slow coronary flow was observed.Medications were administered to manage the patients condition.The patients blood pressure progressively declined and the patient experienced cardiac arrest.Direct current defibrillation and cardiopulmonary resuscitation were performed.Despite all efforts, there was no return of spontaneous circulation, no recordable pulse or blood pressure.The patient was declared dead.The official cause of death was slow flow and bradycardia.It was further reported that the patient also presented with shortness of breath, dyspnea and chest heaviness.Injections of adrenaline, atropine, calcium gluconate 10 ml and amiodarone 150 mg were administered during the procedure.Intra-aortic balloon pump (iabp) and temporary pacemaker implantation (tpi) support were also provided.Patient was shifted to the critical care unit and place on mechanical ventilation.The patient experienced ventricular tachycardia and ventricular fibrillation.Hypotension and cardiac arrest was also noted as causes of death.
 
Additional Manufacturer Narrative
Correction: impact codes.With all the available information, boston scientific concludes: device technical analysis: the device was not returned for analysis; therefore, a technical analysis could not be performed.Device history review: review confirmed that the device met all material, assembly, and performance specifications prior to distribution.Labeling review: review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.Risk review: a risk review was performed and confirmed that the event was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, the cause of the reported event is unknown.The investigation conclusion code of cause not established was selected.No device damages or performance allegations were included within the reported events.A device malfunction could not be confirmed or ruled out due to a lack of allegations and lack of device return.As a device issue could not be confirmed or ruled out, a most likely cause for the reported events could not be determined using the information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RotaLink? Advancer
Common Device Name
catheter, coronary, atherectomy
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
Boston Scientific Corporation
business and technology park,
cork T12 Y K88
EI   T12 YK88
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
+1(763)494-1632
MDR Report Key50073952
Report Number2124215-2026-40682
Device Sequence Number10216894
Product Code MCX
UDI-Device Identifier08714729317739
UDI-Public(01)08714729317739(17)280330(10)38970681
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
P900056
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberH80222782001A0
Device Catalogue NumberH80222782001A0
Device Lot Number0038970681
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/24/2026
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date07/29/2026
Supplement Report FDA Received Date08/24/2026
Date Device Manufactured03/31/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age76 YR
Patient SexFemale
-
-